Wearable lung fluid monitor to guide heart failure treatment
Part of Heart & circulation clinical trials.
This study tests a wearable vest that measures fluid in your lungs without needles. It helps doctors adjust your IV diuretics (water pills) during a hospital stay for heart failure, aiming for more personalized treatment and faster recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 85 years old.
- You are currently in the hospital for acute heart failure, with symptoms like shortness of breath and signs of fluid in the lungs shown on imaging (like chest X-ray).
- A blood test shows a high level of BNP or NT-proBNP (a marker of heart strain) — exact levels depend on your heart rhythm.
- You need IV diuretics (water pills given through a vein) to remove extra fluid.
- Your body size must allow wearing a special vest that measures lung fluid (BMI 20–39, height 150–195 cm, and no chest deformities).
- You do not have severe kidney problems (eGFR below 20) or require dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that measures fluid in your lungs without needles or surgery. It may help your doctor manage heart failure better, especially if you've been in the hospital recently or have symptoms like shortness of breath.
This study uses a noninvasive device (ReDS) to estimate fluid buildup in people hospitalized with acute heart failure. It may help doctors monitor fluid status and guide care more accurately during a hospital stay.
This study tests a remote monitoring device that sends information to your care team to help adjust your heart failure medications. It aims to improve your condition after a hospital stay for heart failure.
This trial tests a small, portable device worn on the chest that measures changes in fluid levels in your lungs to help detect early signs of fluid buildup (pulmonary congestion). This could help people with heart failure avoid emergency hospital visits.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This study tests whether a small wireless sensor can safely measure and track pressure in the left upper heart chamber in people with advanced chronic heart failure. It may help the care team better understand pressure changes that are linked to fluid buildup and symptoms, alongside your usual heart medicines.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.